Delivery Order SPE2DB20D1004-SPE2DB22FG2M7

Award Date 9/27/22
Potential Completion Date 9/28/22
Potential Value $4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,226.75 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 13, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,072.54 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of July 6, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,150.36 for the supply of 1,200,000 units of Bicillin L-A, a prescription medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, on March 8, 2023, with a completion date of March 9, 2023. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,260.47 firm-fixed-price delivery order is for the supply of 2,400,000 units of Bicillin L-A, a prescription medication. The contract has an ultimate completion date of September 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) on April 1, 2024 for the delivery of 1,200,000 units of Bicillin L-A 2ML, a pharmaceutical product. The contract has a ceiling value of $1,175.24 and a firm fixed price pricing type, with an ultimate completion date of April 2, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,200,000 units of Bicillin L-A 2mL to the Defense Logistics Agency (DLA). The $83,660.50 firm fixed-price delivery order has a completion date of February 1, 2023 and was awarded on January 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FL39E) valued at $161,714.88 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. This contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Bicillin L-A, a 1,200,000 unit, 2ml medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $1,175.24. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of December 27, 2023. The contract has a ceiling value of $3,217.62 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $53,627.00 for the supply of Bicillin L-A, a penicillin-based medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. This is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FG2M7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,992.38 for the supply of 2,400,000 units of Bicillin L-A, a 4 ml injectable medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2022.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:54 AM